Subscribe to RSS - legislation


Bid relief bill introduced in House


WASHINGTON – A highly anticipated bill in the House of Representatives that would delay an upcoming second round of Medicare reimbursement cuts in non-bid areas has dropped with a bang.

Bid bill on its way to House floor, VGM says


WASHINGTON – Longtime HME champion Rep. Tom Price, R-Ga., will introduce a bill in early May to delay a second round of Medicare reimbursement cuts in rural areas, according to The VGM Group.

O&P stakeholders add bill to arsenal


WASHINGTON – Rep. Renee Ellmers, R-N.C., has introduced a bill that would halt CMS’s plans to make dramatic changes to coverage for prosthetic devices.

Stabenow, Lankford back bid bill


WASHINGTON – HME stakeholders have added two co-sponsors to a bill in the Senate that would delay a second round of Medicare reimbursement cuts slated for July 1.

Senators push 15-month delay for upcoming bid cuts


WASHINGTON – Just days after CMS released new payment amounts for the latest round of its competitive bidding program, two senators have introduced a bill that would delay a second round of cuts planned for non-bid areas on July 1, 2016.

Industry regroups on bid relief

‘We’ll live to fight next year’

WASHINGTON – The HME industry took a blow last week when competitive bid legislation was left out of an omnibus spending package, but stakeholders are already regrouping.

Rep. Zeldin moves to protect accessories


WASHINGTON – Rep. Lee Zeldin, R-N.Y., has introduced a bill that would prevent CMS from applying competitive bidding pricing to accessories for complex power wheelchairs, AAHomecare and NCART announced today.

Congress looks to repeal medical device tax


WASHINGTON – A bill to repeal the medical device tax passed in the House of Representatives last week.

NHIA to Boehner: Don’t use ASP for home infusion drugs


WASHINGTON – The National Home Infusion Association has asked House Speaker John Boehner to drop a provision in H.R. 2570 that would change the payment structure for infusion drugs under the Part B DME benefit to an average sales price methodology.

Audit bill clears committee


WASHINGTON – The Senate Finance Committee on Wednesday passed a bill to improve the Medicare audit and appeals process.